The Supreme Court expressed concern over steep mark-ups on essential medicines, particularly cancer drugs, describing the pricing disparity as "carnage". This led to a 2.5% decline in the Nifty Healthcare index, with major hospital stocks including Apollo Hospitals and Max Healthcare falling up to 7%. The court's observation on a uniform 16% retail markup cap on medicines may put pressure on the sector's high-margin pharmacy revenue pool.
Read the full original article
Source: thehindubusinessline.com



